Nurix (NRIX) PT Raised to $41 at Stifel Following Q3 Print

October 13, 2026 9:39 AM EDT Send to a Friend
Stifel analyst Stephen Willey raised the price target on Nurix (NASDAQ: NRIX) to $41.00 (from $40.00) while maintaining a Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login